KO vs REGN · P/E 25, rev $47.94B vs P/E 14, rev $14.34B
The Coca-Cola Company (KO) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
The Coca-Cola Company (KO) is a beverages - non-alcoholic company listed on NYSE. It is led by James Quincey.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported KO revenue for 2025-12-31 was $47.94B. Net income was $13.11B. Revenue was up 1.9% from 2024-12-31 to 2025-12-31. KO currently screens at market cap $343.90B and trailing P/E 25.1.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
KO currently screens at market cap $343.90B and trailing P/E 25.1. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the KO and REGN stock pages for the full models.
Not investment advice.